The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory.
iScience. 2021 Dec 17;24(12):103479. doi: 10.1016/j.isci.2021.103479. Epub 2021 Nov 20.
iScience. 2021.
PMID: 34841223
Free PMC article.